Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

There are currently two different ways to get access to Prime Video. You can choose to get it bundled with an Amazon Prime subscription or you can opt for the standalone plan. Within each of these ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Amazon has started issuing payments to eligible Prime members as part of a $2.5 billion settlement over federal allegations that it misled customers. The online retailer agreed to the payouts in ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Prim is the newest venue from the creators of Ghost Baby. Several bottles are on display at the bar. Ross Van Pelt To continue reading this content, please enable ...

The Enquirer's new Going In series is a companion series to Going Up, giving you details and an inside look into the region's new construction projects. Submit suggestions to sfranklin@enquirer.com or ...

Is 170,141,183,460,469,231,731,687,303,715,884,105,727 prime? Before you ask the Internet for an answer, can you consider how you might answer that question without a ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...